HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 96 filers reported holding HARROW HEALTH INC in Q4 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,392,967 | -17.5% | 305,704 | +9.4% | 0.00% | 0.0% |
Q2 2023 | $5,321,700 | +169.1% | 279,501 | +199.0% | 0.00% | – |
Q1 2023 | $1,977,782 | +51.0% | 93,468 | +5.3% | 0.00% | – |
Q4 2022 | $1,309,611 | +22.5% | 88,727 | +0.2% | 0.00% | – |
Q3 2022 | $1,069,000 | +69.7% | 88,565 | +2.3% | 0.00% | – |
Q2 2022 | $630,000 | +6.6% | 86,544 | -0.1% | 0.00% | – |
Q1 2022 | $591,000 | -23.2% | 86,641 | -2.7% | 0.00% | – |
Q4 2021 | $770,000 | -5.5% | 89,081 | -0.6% | 0.00% | – |
Q3 2021 | $815,000 | -3.8% | 89,618 | -1.7% | 0.00% | – |
Q2 2021 | $847,000 | -54.2% | 91,211 | -66.7% | 0.00% | – |
Q1 2021 | $1,849,000 | -17.0% | 273,937 | -15.6% | 0.00% | – |
Q4 2020 | $2,228,000 | +16.4% | 324,675 | -5.2% | 0.00% | – |
Q3 2020 | $1,914,000 | +114.1% | 342,377 | +99.5% | 0.00% | – |
Q2 2020 | $894,000 | +347.0% | 171,605 | +228.2% | 0.00% | – |
Q1 2020 | $200,000 | -49.6% | 52,280 | +2.4% | 0.00% | – |
Q4 2019 | $397,000 | +42.8% | 51,063 | +3.2% | 0.00% | – |
Q3 2019 | $278,000 | -35.2% | 49,500 | +0.4% | 0.00% | – |
Q2 2019 | $429,000 | +75.1% | 49,294 | 0.0% | 0.00% | – |
Q1 2019 | $245,000 | – | 49,294 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,795,000 | $54,534,150 | 17.74% |
Private Capital Management, LLC | 1,416,900 | $20,360,853 | 2.41% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 91,779 | $1,318,864 | 1.86% |
Birchview Capital, LP | 150,000 | $2,155,500 | 1.84% |
Diametric Capital, LP | 286,127 | $4,111,644 | 1.72% |
Ophir Asset Management Pty Ltd | 492,179 | $7,072,612 | 1.67% |
BRAIDWELL LP | 1,808,684 | $25,990,789 | 0.82% |
Westside Investment Management, Inc. | 159,019 | $2,285,117 | 0.66% |
INVICTUS PRIVATE WEALTH, LLC | 400,066 | $5,748,948 | 0.63% |
Portolan Capital Management | 385,964 | $5,546,303 | 0.52% |